Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 23;20(1):e0317794.
doi: 10.1371/journal.pone.0317794. eCollection 2025.

Characteristics influencing COVID-19 testing and vaccination among Spanish-speaking Latine persons in North Carolina

Affiliations

Characteristics influencing COVID-19 testing and vaccination among Spanish-speaking Latine persons in North Carolina

Sandy K Aguilar-Palma et al. PLoS One. .

Abstract

Background: Latine populations in the United States continue to be disproportionately affected by COVID-19 with high rates of infection and mortality. Our community-based participatory research partnership examined factors associated with COVID-19 testing and vaccination within a particularly hidden, underserved, and vulnerable population: Spanish-speaking Latines.

Methods: In 2023, native Spanish-speaking Latine interviewers conducted phone-based structured individual assessments with 180 Spanish-speaking, predominantly immigrant Latines across North Carolina. We used univariate and multivariable logistic regression analyses to examine associations between participant characteristics and COVID-19 testing and vaccination.

Results: Participant mean age was 41.7 (SD = 13), and 77.2% of the sample reported being cisgender women. Most participants reported immigrating from Latin American countries (89.9%), being uninsured (66.1%), and lacking US immigration documentation (51.1%). While most reported ever being COVID-19 tested (83.3%) and ever being vaccinated against COVID-19 (84.4%), only 24% were up to date with vaccination. Nearly half of the sample reported one or more barriers to COVID-19 testing, and over one-quarter reported one or more barriers to COVID-19 vaccination. Higher educational attainment was significantly associated with ever being tested (P = .031). Fewer concerns about the vaccine, including fewer worries about side effects and having more confidence in vaccine effectiveness and safety, was associated with ever being vaccinated (P < .001).

Conclusions: Spanish-speaking Latines face barriers to getting tested and vaccinated against COVID-19. Although ever testing and ever vaccination rates were high, being up to date with recommended vaccinations was low. Educational attainment and concerns about the vaccine were associated with COVID-19 testing and vaccination, respectively. Our findings suggest the need for culturally congruent strategies to address the challenges facing Spanish-speaking Latines in the United States.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Rhodes SD, Tanner AE, Mann-Jackson L, Alonzo J, Hall MA, Bertoni AG, et al.. Increasing COVID-19 testing and vaccination among Spanish speakers in the USA: Protocol for the development and evaluation of the Nuestra Comunidad Saludable intervention using a group-randomised trial design. BMJ Open. 2022;12(11):e066585. doi: 10.1136/bmjopen-2022-066585 - DOI - PMC - PubMed
    1. US Census Bureau. http://www.census.gov/ 2024.
    1. Centers for Disease Control and Prevention. COVID-19 Case Surveillance Public Use Data Atlanta, GA: US Department of Health and Human Services; 2024.
    1. National Center for Immunization and Respiratory Diseases C. Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity. Atlanta, GA; 2021.
    1. Bacong AM, Chu R, Le A, Bui V, Wang NE, Palaniappan LP. Increased COVID-19 mortality among immigrants compared with US-born individuals: a cross-sectional analysis of 2020 mortality data. Public Health. 2024;231:173–8. doi: 10.1016/j.puhe.2024.03.016 - DOI - PMC - PubMed

Substances